Trametinib tablet ( DrugBank: Trametinib )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
279	Huge venous malformation with cervical, oral and pharyngeal diffuse lesion	1

279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion

---

Clinical trials : 14 /  Drugs : 24 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 105

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04258046 (ClinicalTrials.gov)	March 31, 2020	16/1/2020	Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation	Phase II Clinical Trial of MEK Inhibitor Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation (VM)	Venous Malformation;Arterial Disease	Drug: Trametinib tablet	Stanford University	Boston Children's Hospital	Not yet recruiting	12 Years	60 Years	All	30	Phase 2	United States